R. Michael Gendreau, MD, PhD, BS

Gendreau Consulting, LLC
Poway, CA, United States

Dr. Gendreau has served as a Chief Medical Officer for a succession of biotechnology companies for the last 35 years. His focus is on CNS related conditions including chronic pain and rheumatological conditions.

Presentation(s):

• 1610: Digital Acceptance and Commitment Therapy Improves Fibromyalgia Outcomes: Results from a Pivotal, Multi-center, Randomized Controlled Trial

  Monday, November 13, 2023
  2:15 PM – 2:25 PM PT

  Disclosure information not submitted.

• 1612: Design and Validation of a Comparator for Randomized Controlled Trials of a Digital Cognitive Behavioral Therapy

  Monday, November 13, 2023
  2:45 PM – 2:55 PM PT

  Disclosure information not submitted.